Seborrhoeic keratoses appearing in sites of previous psoriasis plaques during treatment with efalizumab

Clinical and Experimental Dermatology

Volumn 34, Issue 8, 2009, Pages

  Vestergaard, M E ^a   Kossard, S ^b,c   Murrell, D F ^a,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EFALIZUMAB;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LENTIGO; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; SEBORRHEIC KERATOSIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; HUMANS; KERATOSIS, SEBORRHEIC; LEG DERMATOSES; MALE; MIDDLE AGED; PSORIASIS; TREATMENT OUTCOME;

EID: 72549111098     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03236.x     Document Type: Article

References (10)

1. Gottlieb AB, Griffiths C, Dubertret L et al. Efficacy and tolerability of oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized dose finding trial. Br J Dermatol 2005 152 : 1219 1227.
2. Yeatman JM, Kilkenny M, Marks R. The prevalence of seborrhoeic keratoses in an Australian population: does exposure to sunlight play a part in their frequency? Br J Dermatol 1997 137 : 411 414.
3. Hafner C, Hartmann A, Real FX et al. Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. J Invest Dermatol 2007 127 : 1883 1885. (Pubitemid 47075362)
4. Flugman SL, McClain SA, Clark RA et al. Transient eruptive seborrheic keratoses associated with erythrodermic psoriasis and erythrodermic drug eruption: report of two cases. J Am Acad Dermatol 2001 45 : S212 14.
5. Williams MG. Acanthomata appearing after eczema. Br J Dermatol 1956 68 : 268 271.
6. Dawn G, McHenry P, Burden AD. Lentigines in psoriatic plaques: are they unique? Clin Exp Dermatol 2001 26 : 459 460.
7. Thielen AM, Kuenzli S, Saurat JH et al. Cutaneous adverse events of biological therapy for psoriasis: review of the literature. Dermatology 2005 211 : 209 217.
8. Costa LA, Berlinchon I, Betlloch I et al. Multiple lentigines arising in resoving psoriatic plaques after treatment with etanercept. Dermatol Online J 2008 14 : 11 13.
9. Santos-Juanes J, Coto J, Mallo S et al. Multiple lentigines confined to resolving psoriatic plaques in a patient treated with adalimumab. Dermatology 2008 216 : 279.
10. Bovenschen HJ, Tjioe M, Vermaat H et al. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals. Br J Dermatol 2006 154 : 880 884.